Diana Walkosz
Appearances
- Responsive biopolymeric nanocomposite systems can be synthesized from natural biopolymers (i.e., polysaccharides and cellulose), which take advantage of their well-defined, three-dimensional network and intrinsic properties…
Presenter
Lewis University - Responsive biopolymeric nanocomposite systems can be synthesized from natural biopolymers (i.e., polysaccharides and cellulose), which take advantage of their well-defined, three-dimensional network and intrinsic properties…
Speakers
- : [COLL] Division of Colloid & Surface Chemistry
Speakers
Clarkson UniversityOak Ridge National LaboratoryUniversity of Illinois at Urbana-ChampaignSRNL & UGAUniversity of Illinois at ChicagoUniversity of ArkansasLewis UniversityAssociate Professor, Dept. of Chemistry and Biochemistry, Queens CollegeUniversity of Delaware - Responsive biopolymeric nanocomposite systems can be synthesized from natural biopolymers (i.e., polysaccharides and cellulose), which take advantage of their well-defined, three-dimensional network and intrinsic properties…
Speakers
- : [COLL] Division of Colloid & Surface Chemistry
Speakers
Clarkson UniversityOak Ridge National LaboratoryUniversity of Illinois at Urbana-ChampaignSRNL & UGAUniversity of Illinois at ChicagoUniversity of ArkansasLewis UniversityAssociate Professor, Dept. of Chemistry and Biochemistry, Queens CollegeUniversity of Delaware - Responsive biopolymeric nanocomposite systems can be synthesized from natural biopolymers (i.e., polysaccharides and cellulose), which take advantage of their well-defined, three-dimensional network and intrinsic properties…
Speakers
- : [COLL] Division of Colloid & Surface Chemistry
Speakers
Clarkson UniversityOak Ridge National LaboratoryUniversity of Illinois at Urbana-ChampaignSRNL & UGAUniversity of Illinois at ChicagoUniversity of ArkansasLewis UniversityAssociate Professor, Dept. of Chemistry and Biochemistry, Queens CollegeUniversity of Delaware - DateMarch 20, 2024The leading hypothesis for Alzheimer's Disease (AD) has traditionally focused on aggregating Amyloid-β into amyloid plaques. However, all therapeutics targeting amyloid plaques have been unsuccessful in clinical trials or had limited efficacy…
Presenter
Speaker
